Geographic variations in the PARADIGM-HF heart failure trial. - Wikidata - awgldk - TriplyDB

Geographic variations in the PARADIGM-HF heart failure trial.

Geographic variations in the PARADIGM-HF heart failure trial.

http://www.wikidata.org/entity/Q37410283

about

Global Variations in Patient Populations and Outcomes in Heart Failure Clinical Trials.Changing the treatment of heart failure with reduced ejection fraction: clinical use of sacubitril-valsartan combination Occlusion in the Flow of New Drugs for Cardiovascular Disease.Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives.Regional Validation and Recalibration of Clinical Predictive Models for Patients With Acute Heart Failure.Integrating New Pharmacologic Agents into Heart Failure Care: Role of Heart Failure Practice Guidelines in Meeting This Challenge.[The new ESC Guidelines for acute and chronic heart failure 2016].Globalization of heart failure trials: no turning back on this paradigm.Sacubitril/valsartan in heart failure with reduced ejection fraction: cost and effectiveness in the Italian context.Sacubitril/Valsartan (LCZ696) in Heart Failure

P2860

Q30235985-1D78769F-E264-4157-AD74-4DCB88E06DEA Q37597972-AD9876DA-9F16-47A3-8C81-FD0D15A4DF40 Q39221282-281BEA81-0C86-4895-9FAE-5B3469025B29 Q42373826-1141B1B4-083C-4FB5-BD54-86F16C80FB55 Q45939197-E0F5DD10-EC96-498D-B0B7-4A754BC5E401 Q50660284-D82F7AFD-D627-4D7E-A47E-93B5B5BC36E6 Q52844963-654DBB35-009B-485D-BE97-6B31371E50C4 Q53963320-718EB20F-B7BA-4D44-8639-1BC11CE1F633 Q55060249-83EF5822-23AB-433C-B554-8DFD28014A14 Q57396137-446653F8-0DC0-4E15-ADE9-83BCC90E301D

P2860

Geographic variations in the PARADIGM-HF heart failure trial.

http://www.wikidata.org/entity/Q37410283

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Geographic variations in the PARADIGM-HF heart failure trial.

@en

Geographic variations in the PARADIGM-HF heart failure trial.

@nl

type

label

Geographic variations in the PARADIGM-HF heart failure trial.

@en

Geographic variations in the PARADIGM-HF heart failure trial.

@nl

prefLabel

Geographic variations in the PARADIGM-HF heart failure trial.

@en

Geographic variations in the PARADIGM-HF heart failure trial.

@nl

P1433

Q37410283-CE0F549D-BD8F-469E-BE75-25273EDDB444

P1476

Q37410283-25EA7BD3-CF2D-41A5-92A5-4AC036EB24F8

P2093

Q37410283-00955D1B-4C48-407C-AD0F-F07E0A8EB5A5

Q37410283-08802D66-550F-408D-9868-39DB75A0944C

Q37410283-13205C23-9935-4411-A145-4651772473FA

Q37410283-27ACAB04-01CF-44AC-95B2-E6EDE9C9A9A3

Q37410283-3864536B-B0B2-475A-B206-C3360A964E3A

Q37410283-394F61FE-A42B-4A35-B542-BB530DE6CFAE

Q37410283-3FE2D3D5-7C68-483A-AAE8-ABA759511607

Q37410283-4AAAC30B-7FEE-42EC-86D2-AAE777B2FB05

Q37410283-4AAF218A-460A-4E0C-8946-2D4A3E4714A2

Q37410283-4ECB2002-4B8D-4684-A6E1-E3CBD0BC2F98

P2860

Q37410283-02578B8C-40A5-4DC0-8329-D5BF3ADEC4D9

Q37410283-072B2611-3EC2-498D-90AB-9656DD3FB8B8

Q37410283-113753D0-96C6-41A0-8290-5FBD36F02464

Q37410283-128E84CF-70F0-4DB6-A85B-4548333450E2

Q37410283-17B7B62E-E7AE-479C-A04A-AAEF80EB263B

Q37410283-1A60957B-966F-4C21-8C9F-ED051B314469

Q37410283-1A7E567D-23BF-4F9A-93B4-5DF414471805

Q37410283-201922BA-4584-43F4-B051-0DDF06D734D3

Q37410283-258D4123-C150-4432-8CF1-EC24318709D1

Q37410283-2C2E34E9-0A06-414A-BDC1-8C0A804581DA

P304

Q37410283-6BEBEB51-F3A2-4D44-B25E-0215B7DCAD88

P31

Q37410283-0B276D59-5B12-408B-A971-07DFE882B777

P356

Q37410283-3B4F87FB-0382-44AE-8E62-4BD5B09F8A13

P433

Q37410283-7EB5F5E5-172A-44BF-A93A-4B7B1BB526E3

P478

Q37410283-07886D7B-B333-44C8-8021-FAC7DE936870

P50

Q37410283-582088D3-E24A-43D4-BCA1-0048A1840F6E

Q37410283-87770E42-64F7-4BFE-AE30-5858B71DA436

Q37410283-8CE1AC1F-BC4D-4C9A-AC47-93AD5E9BBCF3

Q37410283-8FB3AB3A-3DAE-4C8D-B69F-018A4936D6E3

Q37410283-C714613D-827E-4B2B-81FD-6F25EC7D5AA7

Q37410283-DDD109C4-C3C7-49DF-BCD6-0980F3300A4B

Q37410283-F9899EFD-C53C-4C71-B6EE-FD949D7D2D31

P577

Q37410283-445E53D9-05E2-4535-AF5D-5C9740627CC4

P698

Q37410283-080D7DEC-C707-4E72-9DB4-C1DD99447B73

P921

Q37410283-8B32E2D4-A332-46BD-93D2-83858A900661

P932

Q37410283-F4B1672E-6D07-4671-AE73-DD8C18C60FB9

P356

P1433

European Heart Journal

P1476

Geographic variations in the PARADIGM-HF heart failure trial

@en

P2093

Adel R Rizkala

http://www.w3.org/2001/XMLSchema#string

Dragos Vinereanu

http://www.w3.org/2001/XMLSchema#string

Efrain Gomez

http://www.w3.org/2001/XMLSchema#string

Felipe Martinez

http://www.w3.org/2001/XMLSchema#string

Iain B Squire

http://www.w3.org/2001/XMLSchema#string

Iván Mendoza

http://www.w3.org/2001/XMLSchema#string

Jan Bĕlohlávek

http://www.w3.org/2001/XMLSchema#string

Jean L Rouleau

http://www.w3.org/2001/XMLSchema#string

Jianjian Gong

http://www.w3.org/2001/XMLSchema#string

Juan Luis Arango

http://www.w3.org/2001/XMLSchema#string

P2860

Geographic differences in heart failure trials

Angiotensin-neprilysin inhibition versus enalapril in heart failure

Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF).

Comparable benefit of β-blocker therapy in heart failure across regions of the world: meta-analysis of randomized clinical trials.

Global epidemiology of atrial fibrillation.

Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial.

Antithrombotic treatment for stroke prevention in atrial fibrillation: The Asian agenda.

Falling Cardiovascular Mortality in Heart Failure With Reduced Ejection Fraction and Implications for Clinical Trials.

Global variation in clinical profile, management, and post-discharge outcomes among patients hospitalized for worsening chronic heart failure: findings from the ASTRONAUT trial.

International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction.

P304

3167-3174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHW226

http://www.w3.org/2001/XMLSchema#string

P433

41

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

Pardeep S. Jhund

Søren L Kristensen

P577

2016-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27354044

http://www.w3.org/2001/XMLSchema#string

P921

P932

5106574

http://www.w3.org/2001/XMLSchema#string